Department Of Dermatology 1

1. Mycological Profile and Associated Factors Among Patients with Dermatophytosis in Astana, Kazakhstan
2. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
3. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
4. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
5. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
6. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
7. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
8. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
9. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
10. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
11. The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
12. The Chronic Angioedema Registry (CARE): Rationale, Methods and Implementation
13. Unmet needs in hereditary angioedema: an international survey of physicians
14. Unmet needs in hereditary angioedema: an international survey of physicians
15. Unmet needs in hereditary angioedema: an international survey of physicians
16. Unmet needs in hereditary angioedema: an international survey of physicians
17. One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis
18. One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis
19. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
20. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
21. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
22. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
23. Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
24. Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
25. Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
26. Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
27. Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
28. Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
29. Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
30. Can Synthetic Data Allow for Smaller Sample Sizes in Chronic Urticaria Research?
31. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
32. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
33. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
34. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
35. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
36. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
37. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
38. Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife—CURE insights
39. Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife—CURE insights
40. Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife—CURE insights
41. Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife—CURE insights
42. Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife—CURE insights
43. Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife—CURE insights
44. Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife—CURE insights
45. Sex matters in CSU: Women face greater burden and poorer urticaria control, especially in midlife—CURE insights
46. Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry
47. Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry
48. Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry
49. Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry
50. Unmet Needs in Treatment Escalation for Chronic Spontaneous Urticaria: Findings From the CURE Registry
1 2 3 4